Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Glutaminase inhibition (GLSi) has promising activity against certain cancers. Here, the authors show that GLSi has no effect on multiple mouse models of pancreatic cancer and characterize the metabolic pathways activated in response to GLSi whose concomitant inhibition may have therapeutic utility.
Enregistré dans:
Auteurs principaux: | Douglas E. Biancur, Joao A. Paulo, Beata Małachowska, Maria Quiles Del Rey, Cristovão M. Sousa, Xiaoxu Wang, Albert S. W. Sohn, Gerald C. Chu, Steven P. Gygi, J. Wade Harper, Wojciech Fendler, Joseph D. Mancias, Alec C. Kimmelman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3c1c97f9f96f44b8b385caffd639b374 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Targeting glutamine metabolism slows soft tissue sarcoma growth
par: Pearl Lee, et autres
Publié: (2020) -
Glutamine metabolism regulates endothelial to hematopoietic transition and hematopoietic lineage specification
par: Leal Oburoglu, et autres
Publié: (2021) -
A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
par: Manabu Kodama, et autres
Publié: (2020) -
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
par: Ru Chen, et autres
Publié: (2017) -
Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia
par: Yuanyuan Wang, et autres
Publié: (2019)